Videos

Videos
Module 1: Understanding the Burden of nAMD and DME
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD summarize the socioeconomic burden and unmet needs associated with the management of nAMD and DME.
Videos
Module 1: Alternative Dosing Strategies for nAMD and DME
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD summarize the socioeconomic burden and unmet needs associated with the management of nAMD and DME.
Videos
Module 2: nAMD and DME Treatment Guidelines
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD assess the benefits and limitations of traditional VEGF inhibitors for the treatment of nAMD and DME.
Videos
Module 2: Key Clinical Trial Data for Traditional VEGF Inhibitors
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD assess the benefits and limitations of traditional VEGF inhibitors for the treatment of nAMD and DME.
Videos
Module 2: Unmet Needs of Traditional VEGF Inhibitors in the Treatment of nAMD and DME
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD assess the benefits and limitations of traditional VEGF inhibitors for the treatment of nAMD and DME.
Videos
Module 3: Novel Agents for nAMD and DME Emerging Therapies for nAMD and DME
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD evaluate the clinical data of newer/emerging treatment options for nAMD and DME.
Videos
Module 4: Understanding the Need for Improved Intraocular Drug Delivery
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD examine recent innovations in drug delivery systems for nAMD and DME.
Videos
Module 4: Novel Drug Delivery Methods for nAMD and DME—Ranibizumab PDS
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD examine recent innovations in drug delivery systems for nAMD and DME.
Videos
Module 4: Novel Drug Delivery Methods for nAMD and DME—Dexamethasone Intravitreal Implants
Ferhina S. Ali, MD, MPH and Russell Spjut, PharmD examine recent innovations in drug delivery systems for nAMD and DME.